Table 1:
Control | NPSLE | SLE | P Value | |
---|---|---|---|---|
Sample size | 20 | 19 | 19 | – |
Age (yr) | 40.1 ± 14.6 | 44.2 ± 13.4 | 41.9 ± 14.1 | .822 |
Disease duration (yr) | – | 18.0 ± 10.1 | 17.4 ± 9.3 | .954 |
Cumulative prednisolone dosage (g) | – | 53.8 ± 39.8 | 48.9 ± 28.9 | .317 |
Radiologic abnormalities (prevalence) (%) | ||||
Lacunar infarct | – | 21 | 11 | .179 |
Chronic infarct | – | 16 | 11 | .350 |
Microbleeds | – | 11 | 11 | 1.000 |
Neuropsychiatric symptoms (prevalence) (%) | ||||
Seizure | – | 53 | – | – |
Confusion | – | 21 | – | – |
Stroke | – | 16 | – | – |
Psychosis | – | 11 | – | – |
Cognitive impairment | – | 5 | – | – |
Note:— – indicates not applicable.